Pinnacle Bancorp, Inc. Biogen Inc. Transaction History

Pinnacle Bancorp, Inc.

$336 Million
Q2 2024

A detailed history of Pinnacle Bancorp, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Pinnacle Bancorp, Inc. holds 45 shares of BIIB stock, worth $8,492. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 45 -0.0%

Holding current value

$8,492

Previous $9,000 11.11%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$187.54 - $223.02 $50,448 - $59,992	-269 Reduced 85.67%	45 $9,000
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $18,020 - $22,705	-93 Reduced 22.85%	314 $66,000
Q4 2021 Jan 19, 2022	SELL	$223.92 - $287.77 $15,674 - $20,143	-70 Reduced 14.68%	407 $98,000
Q3 2021 Oct 12, 2021	SELL	$282.99 - $369.05 $1,414 - $1,845	-5 Reduced 1.04%	477 $135,000
Q2 2021 Jul 15, 2021	SELL	$259.0 - $414.71 $131,054 - $209,843	-506 Reduced 51.21%	482 $167,000
Q1 2021 Apr 26, 2021	SELL	$242.95 - $284.63 $7,531 - $8,823	-31 Reduced 3.04%	988 $276,000
Q4 2020 Jan 13, 2021	BUY	$236.26 - $355.63 $16,538 - $24,894	70 Added 7.38%	1,019 $250,000
Q2 2020 Jul 07, 2020	BUY	$258.66 - $342.55 $2,586 - $3,425	10 Added 1.06%	949 $254,000
Q4 2019 Jan 10, 2020	SELL	$220.06 - $304.07 $23,326 - $32,231	-106 Reduced 10.14%	939 $279,000
Q3 2019 Oct 08, 2019	SELL	$217.44 - $243.88 $48,706 - $54,629	-224 Reduced 17.65%	1,045 $243,000
Q2 2019 Jul 08, 2019	BUY	$219.29 - $241.72 $5,482 - $6,043	25 Added 2.01%	1,269 $297,000
Q1 2019 Apr 05, 2019	SELL	$216.71 - $338.96 $12,785 - $19,998	-59 Reduced 4.53%	1,244 $294,000
Q4 2018 Mar 20, 2019	BUY	$278.5 - $352.75 $362,885 - $459,633	1,303 New	1,303 $392,000

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Bancorp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Bancorp, Inc. with notifications on news.

Account

Pinnacle Bancorp, Inc. Biogen Inc. Transaction History